Fig. 10From: Aptamer-labeled PLGA nanoparticles for targeting cancer cellsFlow cytometry analysis—control cells (purple); normal cells treated with Apt-NR-PLGA NPs (blue) and tumor cells treated with Apt-NR-PLGA NPs (green)Back to article page